Latest filing published 18 Mar 2025 for Inotiv, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -83.5%Entry US$26.18 · Close at T+365 US$4.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Beth Taylor: trading record in brief
Beth Taylor (finance chief) discloses dealings in 2 companies, chiefly Endocyte Inc and Inotiv, Inc. We count 50 filings; the first trade dates from 6 February 2014 and the latest from 14 March 2025.
Both buying and selling appear: 6 purchases worth €270k, against 5 sales worth €260k. Taken together, the purchases exceed the sales by €11k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 22 share grants and 6 option exercises. Since January 2025: no purchases and 2 sales on the market.
A typical purchase (the median) is worth €31k.
The newest entry dates from 18 March 2025: a share grant, in Inotiv, Inc. The last purchase on record was published on 22 February 2022, which is 1,721 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Beth Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares0Common StockSEC:0001062993-25-005698:0
- 4,370 shares@ US$4.00619.9% of flowCommon StockSEC:0001062993-25-003060:0
- 2,054 shares@ US$4.4655.2% of flowCommon StockSEC:0001062993-25-001624:0
- 20,000 shares0Common StockSEC:0001062993-24-015122:0
- 5,000 shares0Common StockSEC:0001062993-23-004285:0
- 5,917 shares0Common StockSEC:0001062993-23-001180:0
- 5,000 shares@ US$23.071560.3% of flowCommon SharesSEC:0001179110-22-001480:0Canonical exit: 19 May 2022 (T+90)
- 40,000 shares0Common SharesSEC:0001179110-22-001378:0
- 214 shares0Common SharesSEC:0001179110-21-011144:0
- 1,332 shares0Common SharesSEC:0001179110-21-009623:0
- 2,154 shares@ US$23.1424.5% of flowCommon SharesSEC:0001179110-21-005394:0Canonical exit: 11 Aug 2021 (T+90)
- 880 shares0Common SharesSEC:0001179110-21-005180:0
- 5,000 shares@ US$17.70Common SharesSEC:0001179110-21-002958:0Canonical exit: 3 Jun 2021 (T+90)
- 5,995 shares0Common SharesSEC:0001179110-20-011699:0
- 10,000 shares0Common SharesSEC:0001179110-20-007222:0
- 5,067 shares@ US$4.38Common SharesSEC:0001179110-20-006457:0Canonical exit: 17 Aug 2020 (T+90)
- 4,933 shares@ US$4.42Common SharesSEC:0001179110-20-006457:1Canonical exit: 18 Aug 2020 (T+90)
- 3,300 shares@ US$4.52Common SharesSEC:0001179110-20-006457:2Canonical exit: 19 Aug 2020 (T+90)
- 59,509 shares@ US$24.0050.4% of flowCommon StockSEC:0001104659-18-074345:0
- 1,250 shares@ US$24.001.1% of flowCommon StockSEC:0001104659-18-074345:1
- 1,875 shares@ US$24.001.6% of flowCommon StockSEC:0001104659-18-074345:2
- 7,500 shares@ US$24.006.4% of flowCommon StockSEC:0001104659-18-074345:4
- 15,000 shares@ US$24.0012.7% of flowCommon StockSEC:0001104659-18-074345:5
- 12,500 shares@ US$24.0010.6% of flowCommon StockSEC:0001104659-18-074345:6
- 16,073 shares@ US$3.552.0% of flowCommon StockSEC:0001179110-18-014138:0
25 of 49 declarations
